skip to primary navigationskip to content

Jean Abraham

Dr Jean AbrahamJean Abraham


Graduate Students

Dr Jean Abraham is pleased to consider applications from prospective graduate students.

Research Interests

Dr Abraham is co-author of the Anglia Cancer Network Breast Cancer Chemotherapy Treatment Algorithms, which defines the treatment pathways for breast cancer in the neo-adjuvant, adjuvant and metastatic setting for patients within the Anglia cancer network. She has a particular interest in the management and treatment of high risk and hereditary breast cancers. She is actively involved in leading the design and development of biomarker directed clinical trials, which aims to treat patients in a more targeted fashion.

Her current research focus is in cancer pharmacogenetics (the relationship between genetics, drug response and/or drug toxicity). Her work in breast cancer pharmacogenetics investigates the development of biomarkers to predict for toxicity and response for chemotherapy and hormone therapy. She is Chief Investigator of the national pharmacogenetics study PGSNPS and also pharmacogenetics lead on several UK breast cancer studies. She has established research collaborations throughout the UK, USA, Japan and the Netherlands.

Pubmed journal articles - pubmed